Press Release: Abacus dx Announces Partnership with Epredia
Abacus dx Announces Commercial Partnership with Epredia in Australia & New Zealand’s Clinical Market Sector
Brisbane, 1st July 2024
Abacus dx Announces Commercial Partnership with Epredia in Australia & New Zealand’s Clinical Market Sector
Brisbane, 1st July 2024
Products are for professional/laboratory use only.
Controls are vital in any experiment to reliably distinguish your results from background variation and non-specific effects. Here we will discuss some essential controls for flow cytometry you must consider to ensure publication quality flow cytometry data.